Concepedia

David Covini

DC

Statistics

Publications

5

Citations

824

H-Index

5

Active since

2005

Affiliations

Boehringer Ingelheim (Austria)(Current)

David Covini is an author at Boehringer Ingelheim (Austria) specializing in drug discovery, drug design, and pharmacology.

Publications per year

2005–2024

5

Publications

5

Drugging an undruggable pocket on KRAS

Dirk Kessler, Michael Gmachl, Andreas Mantoulidis et al. · Proceedings of the National Academy of Sciences · 2019 · 434 citations · Full text

, , +15

Furan-2-ylmethylene Thiazolidinediones as Novel, Potent, and Selective Inhibitors of Phosphoinositide 3-Kinase γ

Vincent Pomel, Jasna Klicić, David Covini et al. · Journal of Medicinal Chemistry · 2006 · 209 citations · Full text

, , +16

Highly Selective PTK2 Proteolysis Targeting Chimeras to Probe Focal Adhesion Kinase Scaffolding Functions

Johannes Popow, Heribert Arnhof, Gerd Bader et al. · Journal of Medicinal Chemistry · 2019 · 142 citations · Full text

, , +13

Discovery and Development of a New Class of Potent, Selective, Orally Active Oxytocin Receptor Antagonists

Anna Quattropani, Jérôme Dorbais, David Covini et al. · Journal of Medicinal Chemistry · 2005 · 29 citations · Full text

, , +17

Synthesis of Indazoles via N–N Bond-Forming Oxidative Cyclization from 2-Aminomethyl-phenylamines

Anna Schoeggl Toledano, Jacqueline Bitai, David Covini et al. · Organic Letters · 2024 · 10 citations

, , +6

1–5 of 5